Status:
UNKNOWN
IMPACt of an Enhanced Screening Program on the Detection of Non-AIDS NEOplasms in HIV Patients
Lead Sponsor:
Felix Gutierrez
Collaborating Sponsors:
Instituto de Salud Carlos III
Hospital General Universitario Reina Sofía de Murcia
Conditions:
HIV/AIDS
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction: The incidence of malignancies is higher in the HIV-infected population than in the general population, and it is already one of the leading causes of death in people living with the viru...
Detailed Description
Non-AIDS-Defining Cancers (NADCs) are an important cause of morbidity and mortality in the population living with the human immunodeficiency virus (PLHIV), being currently one of the most frequent cau...
Eligibility Criteria
Inclusion
- Male ≥40 years or woman ≥18 years
- Informed Consent signed
Exclusion
- Active AIDS defining disease
- Antecedent of cancer
- Terminal disease
- Pregnancy or breastfeeding
- Patient rejection
Key Trial Info
Start Date :
November 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
4638 Patients enrolled
Trial Details
Trial ID
NCT04735445
Start Date
November 11 2019
End Date
June 30 2023
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Elche, Alicante, Spain, 03203